CleverCUP · The Clean-Catch Robot

The clean catch,
automated.

Manual urine collection contaminates 3 in 10 diagnostic samples. CleverCUP is a single-use, anatomy-aligned device that separates first-void urine from the clean midstream automatically — eliminating diagnostic errors at the source.

TRL 4
validated functional prototype, pre-revenue
₹1.52 Cr
ecosystem support raised to date
7
patent jurisdictions filed
CleverCUP automatic midstream urine collection device, showing the labia-separating funnel and labelled collection chambers
CleverCUP Aura Patent-pending · TRL 4 · ready for pilot deployment
The problem

Most UTI tests fail before they reach the lab

Correct midstream collection asks a patient to part labia with one hand, clean, then pee a small amount in the commode, hold, aim and give midstream sample in the universal urine collector, without guidance. Most don't get it right.

30%
of manually collected samples show contamination from skin and perineal microflora, producing false positives.
51%
of uropathogens identified in India are now multi-drug resistant — inaccurate testing is a direct driver of antimicrobial resistance.
36L
urine tests prescribed daily to UTI-suspected OPD patients across India — CleverCUP is built for this diagnostic revolution.
How it works

One void, three streams, sorted automatically

CleverCUP uses a fluidic pathway — not electronics — to route each stage of the void into its own chamber, in the order it's produced. No stopping, repositioning, or manual timing required; just use and seal.

Stage 1 — FVU

First-void urine

The initial ~10ml, carrying skin and perineal contaminants, fills a dedicated compartment and locks in place via the ball-float valve.

Stage 2 — MSU

Midstream urine

Once the valve locks, clean midstream flow diverts automatically into a separate sterile chamber — ready for culture and sensitivity testing.

Stage 3 — LSU

Late-stream urine

A third compartment captures late-stream flow, enabling full urine-profile analysis — useful for urinary bladder microbiome analysis.

How a sample is sorted
FUNNEL INTAKE BALL-FLOAT VALVE FVU · DISCARDED MSU · TESTED
First-void (contaminated) Midstream (clean, sent for culture)
The valve locks after ~10ml, diverting first-void urine before the clean midstream ever reaches the collection chamber.
From notebook to prototype

The product development journey

Four stages from first hand-drawn sketch to a validated, TRL 4 device — same funnel-and-valve concept, refined through every iteration.

Early hand-drawn engineering notebook sketches for CleverCUP's chamber and segregator design
01Sketch & concept
3D CAD modelling of the CleverCUP funnel and valve mechanism on screen
02CAD & engineering
Early 3D-printed physical prototype of CleverCUP on the test bench
03Physical prototyping
The validated CleverCUP device and collection tubes alongside its product information card
04Validated device

A modular plug and play device

To cater the four distinct care settings from the single technology.

Flagship

Aura

Restroom-independent

Manages the entire void in privacy curtains for PHCs and rural health camps with no fixed restroom.

Supported by BIRAC under BIG-'24

Urban

Commode-optimised

Palm-sized, ergonomic design built for urban diagnostic chains and standard home bathrooms.

Supported by BFI & m-Pragati under NAMAH
POCT

Triage

Dipstick-integrated

30-second real-time screening for seamless sample triaging, effective urine culture and AST of dipstick positives only.

Supported by IKP Knowledge Park (ICTPH), under Health Access Catalyst

Omni

Metabolic markers (ACR)

Mechanism is optimised for cardiometabolic disease screening and monitoring — improved ACR efficiency.

Supported by Novo Nordisk & FITT, under Healthier India Program
Market opportunity

Sized from prescriptions, not aspiration

The market is built bottom-up from the ~60,000 registered hospitals already prescribing urine culture tests to UTI-suspected patients.

TAM
₹95 Cr+

36 lakh tests/day × 264 working days, at a tentative ₹50 unit price.

SAM
70%

Share of TAM addressable through women's UTI screening alone.

SOM
50%

Of SAM targeted as the realistic serviceable segment.

3-year target
₹166 Cr

Potential revenue at 10% capture of SOM within three years.

Evidence & validation

Validated in the lab, moving through clinical pilots

Proof-of-principle was established through in-vitro testing with artificial urine spiked with known uropathogens, followed by clinician and patient surveys.

0
growth of first-void bacteria detected in the MSU chamber during lab trials
80%
of surveyed patients were unaware of correct midstream collection technique
80%
of surveyed patients and providers expressed intent to adopt CleverCUP
2
hospital pilots — underway at ESIC Faridabad, planned at PGIMER Chandigarh
Petri dish cultures from CleverCUP's in-vitro validation: FVU and MSU control plates compared against CleverCUP's segregated MSU1 and MSU2 chambers, plus confirmatory colony PCR gel
In-vitro validation with spiked artificial urine: control plates against CleverCUP's segregated chambers, confirmed by colony PCR — significant reduction in first-void CFU count, with no growth carried into the MSU2 chamber.
Patent · 202311085431
Design · 440405-001
PCT · PCT/IN2024/052375
NPE filed · US, EPO, UAE, AU, China, Singapore
Technology developed and assigned by BRIC-THSTI under School of Diagnostic Innovation in Biodesign, a Department of Biotechnology, Govt. of India supported programme.

Ecosystem support: ~₹1.52 Cr

DBT-SiB, BRIC-THSTI
BIRAC BIG '24
Novo Nordisk & FITT
IKP Knowledge Park
Venture Centre Pune
BFI & BVT Interconnect Fellowship
BFI NAMAH, m-Pragati IIT Delhi
RCB BBB, NCR Biotech Science Cluster
Our journey

From a first ribbon to a working platform

A chronological record of the milestones, foundation days, and exhibition floors that have shaped CleverCUP since its first public showing in November 2024.

Group photo on stage at the 1st Foundation Day of BRIC, 9 November 2024, with guest of honour Shri Amitabh Kant
9 NOV 2024

RaSE Challenge Winner

CleverCUP named a Race-from-Science-to-Entrepreneurship winner at the 1st Foundation Day of BRIC, Department of Biotechnology — guest of honour Shri Amitabh Kant, G20 Sherpa & former CEO, NITI Aayog.

Devhuti Palan receiving a cheque for the RaSE Competition Winner special award, sponsored by Dr Anand Deshpande of Persistent Systems
26 FEB 2025

₹1 lakh special recognition

Honoured at the 39th Foundation Day of the Department of Biotechnology, with a ₹1 lakh award from Dr. Anand Deshpande, Founder & Chairman of Persistent Systems, to support project development.

Devhuti Chetan Palan receiving the Medicall Healthcare Innovation Awards 2025 Gold Award and a one lakh rupee cheque
26 JUL 2025

Medicall Gold Award

Gold Award and a ₹1 lakh prize at the Medicall Healthcare Innovation Awards 2025, Medicall Expo Chennai — hosted by Bio Vedas and Anna University.

Certificate handover on stage at IKMC 2025 Beyond the Blueprint, Platform Technologies category
27 OCT 2025

First prize, IKMC'25 TechX

First prize (₹75,000) in the SSD category of TechX at IKMC'25, hosted by IKP Knowledge Park.

Arundhati Healthcare's booth 27 at Bharat Innovates 2025
BHARAT INNOVATES 2025

On the exhibition floor

CleverCUP's public debut at booth 27 — the first time visitors outside the lab could see, hold, and ask questions about the device.

CleverCUP Aura and Triage variants on display at SINE, IIT Bombay
SINE, IIT BOMBAY

The full platform, on the table

At SINE, IIT Bombay — this time with Aura, Urban, Triage, and Omni all on display side by side.

Presenting CleverCUP Aura on stage at THSTI's 17th Foundation Day, 15 July 2026
15 JUL 2026

On stage at THSTI's 17th Foundation Day

Presenting CleverCUP Aura to the institute that helped build it — from a Biodesign Fellowship prototype to a platform with four variants in the field.

More moments along the way
Team visit to T-Works, Government of Telangana's prototyping and manufacturing hub
At T-Works, Telangana's state prototyping & manufacturing hub
Group photo with mentors and the Biodesign Fellowship community
With mentors and the Biodesign Fellowship community at BRIC-THSTI
Larger group photo on stage at the 39th DBT Foundation Day
On stage at the 39th Foundation Day of the Department of Biotechnology
Arundhati Healthcare team at SINE, IIT Bombay
At SINE, IIT Bombay
Team

A small clinical and product team, closely advised

Devhuti Palan

Devhuti Palan

Founder & CEO
DBT-THSTI Biodesign Fellow '23 · B.Tech Genetic Engineering, SRM IST Chennai
Dr. Sadia Iqrar

Dr. Sadia Iqrar

Clinical Validation & R&D Lead
Ph.D. Biotechnology, Jamia Hamdard, Delhi
Uchit Mehta

Uchit Mehta

Product Lead
7+ yrs consumer-centric design · B.Industrial Design, Raffles, Australia
Shivang Dwivedi

Shivang Dwivedi

Lab Validation, Screening Associate
M.Sc. Zoology (final year), CSJMU Kanpur
Jenil Thacker

Jenil Thacker

QC/QA & Documentation
Bachelor of Pharmacy, BNCP Mumbai
Advised by: Dr. Niraj Kumar & Dr. Susmita Chaudhuri (BRIC-THSTI, DBT SiB) · Dr. Satya Prakash Dash (CEO, IKP) · Dr. V. Premnath (Director, Venture Center Pune) · Dr. Ashutosh Pastor (FITT, IIT Delhi) · Dr. Suman Gupta (BRIC-RCB, BBB) · Dr. Shinjini Bhatnagar (Sr. Prof. THSTI, AIIMS Delhi) · Dr. Neelam Taneja (HOD Med. Micro., PGIMER Chandigarh) · Dr. Raunak Bir (ESIC Medical College, Faridabad) · Dr. Ravikrishnan E. & Dr. Dinesh K.S. (m-Pragati, IIT Delhi) · Dr. Johnathan Pillai (MD, Premom).
Access & pricing

Priced for public health programmes, not just private hospitals

Imported midstream devices run ₹200–₹450. CleverCUP targets ₹20–25 per unit for B2B and ₹50 retail, with an ex-factory cost of ₹8–10 at scale.

₹20–25
CleverCUP (B2B)
₹200
Peezy
₹300
Whiz
₹450
Colli-Pee

Public health programmes

Integrates into RMNCH+A, maternal care, and school-based screening under existing government health infrastructure.

Hospitals & diagnostic chains

Institutional supply to PHCs, telemedicine labs, NGOs, and diagnostic networks, reducing repeat-test costs from contamination.

Patients, direct

Available through pharmacies and e-commerce for home use, with dignity-first design for women, elderly men, and children.

Company

Arundhati Healthcare Private Limited

Incorporated in 2025 and based in Delhi NCR, developing diagnostic-grade collection devices under the SIB Biodesign Fellowship at BRIC-THSTI, with clinical advisors from PGIMER Chandigarh and ESIC Faridabad.

Outstanding Idea
National Biotech Hackathon 2024 at BRIC ILS Bhubaneshwar
NBRCOM 2024
Second prize - Young Researcher Award, AIIMS New Delhi & SYBS
Pre-Finalist
NBEC 2024 at C-CAMP
For investors & partners

Raising for global product launch

We're onboarding pilot sites, institutional partners, and distribution channels ahead of CDSCO approval and commercial scale-up, backed by BFI m-Pragati IIT Delhi, DBT-BRIC-THSTI, and RCB BBB.

ContactDevhuti Palan, Founder & CEO — arundhatihealthcare@gmail.com — +91 84699 77244
Registered office2nd Floor, Plot No. 4, Minarch Tower, Sector-44, Gurugram, Haryana 122003, India
IncubationBSC BioNEST Bio-Incubator (BBB), BRIC-RCB, NCR Biotech Science Cluster